Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825

Related Experiment Video

Updated: May 9, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Michael Weller, W K Alfred Yung

    Neuro-Oncology
    |July 19, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
    08:11

    A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

    Published on: September 26, 2011

    Related Experiment Videos

    Last Updated: May 9, 2026

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:33

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
    08:11

    A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

    Published on: September 26, 2011

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
    Mechanism of Angiogenesis01:10

    Mechanism of Angiogenesis

    Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

    The Lancet. Oncology·2018

    Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.

    Neuro-oncology·2018

    A tissue-based draft map of the murine MHC class I immunopeptidome.

    Scientific data·2018

    DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

    Neuro-oncology·2018

    Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.

    European journal of cancer (Oxford, England : 1990)·2018

    Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

    Cancer treatment reviews·2018

    Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trial.

    Neuro-oncology·2026

    Longitudinal PET RANO 1.0 and RANO 2.0 response assessment in vorasidenib-treated IDH-mutant gliomas: the VORAFET study.

    Neuro-oncology·2026

    Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibition.

    Neuro-oncology·2026

    Early versus late venous thromboembolism in patients with newly diagnosed high-grade gliomas.

    Neuro-oncology·2026

    EGFRvIII overexpression and loss of mouse-specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model.

    Neuro-oncology·2026

    EGFRvIII-Positive Glioblastoma: Structural Rewiring, Immune Microenvironmental Remodeling, and Therapeutic Resistance.

    Neuro-oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us